Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BTAI | US
-0.00
-0.74%
Healthcare
Biotechnology
30/06/2024
18/10/2024
0.57
0.57
0.59
0.56
BioXcel Therapeutics Inc. a commercial-stage biopharmaceutical company engages in utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. Its commercial product IGALMI a sublingual film formulation of dexmedetomidine for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. The company also continues to conduct clinical trials evaluating BXCL501 for the acute treatment of agitation in Alzheimer's disease patients and for adjunctive treatment of patients with major depressive disorder as well as in the community for agitation associated with bipolar disorders and schizophrenia. In addition it is developing BXCL502 as a potential therapy for chronic agitation in dementia; and BXCL701 an investigational orally administered systemic innate immunity activator for the treatment of rare forms of prostate cancer and advanced solid tumors that are refractory or treatment naïve to checkpoint inhibitors. The company was incorporated in 2017 and is headquartered in New Haven Connecticut.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
68.5%1 month
87.9%3 months
92.8%6 months
84.3%-
-
3.97
-1.39
1.58
-0.75
28.48
-
-104.30M
23.05M
23.05M
-
-1.49K
-
141.60
-1.77K
0.78
1.63
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.08
Range1M
0.17
Range3M
0.73
Rel. volume
0.30
Price X volume
75.83K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Tonix Pharmaceuticals Holding Corp | TNXP | Biotechnology | 0.18 | 25.20M | 0.33% | n/a | 21.99% |
iBio Inc | IBIO | Biotechnology | 2.87 | 24.79M | 0.70% | n/a | 20.92% |
Caladrius Biosciences Inc | LSTA | Biotechnology | 2.97 | 24.71M | 1.02% | n/a | 0.58% |
PolyPid Ltd | PYPD | Biotechnology | 3.59 | 24.71M | 4.66% | n/a | 689.01% |
RenovoRx Inc. Common Stock | RNXT | Biotechnology | 1 | 23.99M | 0.00% | n/a | 0.00% |
Bolt Technology Corp | BOLT | Biotechnology | 0.6264 | 23.97M | -1.82% | n/a | 22.00% |
ImmunoCellular Therapeutics Ltd | IMUC | Biotechnology | 0.14 | 23.43M | 1.45% | 0.02 | -82.78% |
Aligos Therapeutics Inc | ALGS | Biotechnology | 7.25 | 23.17M | 0.55% | n/a | 14.63% |
Cyclo Therapeutics Inc | CYTH | Biotechnology | 0.774 | 22.21M | -1.39% | n/a | -58.50% |
Pieris Pharmaceuticals Inc | PIRS | Biotechnology | 16.919 | 22.07M | -0.06% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.9 | 19.65M | 2.38% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 1.03 | 18.60M | 5.10% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.538 | 7.80M | -6.65% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2201 | 3.95M | 4.26% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.76M | 1.92% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.01 | 897.66K | -12.28% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.38 | 0 | 0.37% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.92 | 0 | -8.84% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4801 | 0 | -10.26% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.045 | 0 | -2.34% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.75 | 0.53 | Cheaper |
Ent. to Revenue | 28.48 | 4,005.99 | Cheaper |
PE Ratio | - | 40.42 | - |
Price to Book | 3.97 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 92.81 | 72.92 | Riskier |
Debt to Equity | -1.39 | -1.24 | Cheaper |
Debt to Assets | 1.58 | 0.25 | Expensive |
Market Cap | 23.05M | 3.78B | Emerging |